We are the first company in the world to pave the way for the introduction of medicinal cannabis into the treatment of patients. The name Tikum Olam that goes along with the philosophy "Repair The World" inspires us to continue our work in the research and development of medicinal cannabis preparations that improve the quality of life of the thousands of patients who trust us.
Tikun Olam Europe's signature medical cannabis is cultivated using exclusively high-level scientific techniques. It features the exclusive use of cannabis strains that have been genetically modified for maximum effectiveness in symptomatic relief. Especially for the development of its pharmaceutical formulations, Tikun Olam Europe has selected from a range of cannabis strains of Tikun Olam Israel, those covering the widest range of medical cases, for which there is a proven effectiveness, based on clinical studies.
Strain Profile |
THC Dominant |
THC content approx. 31% and CBD content ≤ 1% Indica / Sativa Hybrid Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content approx. 31% and CBD content ≤ 1% Indica / Sativa Hybrid Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content approx. 30% and CBD content ≤ 1% Indica / Sativa Hybrid Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content approx. 30% and CBD content ≤ 1% Indica / Sativa Hybrid Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content approx. 28% and CBD content ≤ 1% Indica / Sativa Hybrid Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content approx. 28% and CBD content ≤ 1% Indica / Sativa Hybrid Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content approx. 27% and CBD content ≤ 1% Indica / Sativa Hybrid Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content approx. 27% and CBD content ≤ 1% Indica / Sativa Hybrid Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content approx. 21% and CBD content ≤ 1% Indica / Sativa Dominant Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content approx. 21% and CBD content ≤ 1% Indica / Sativa Dominant Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content around 19-20% and CBD content ≤ 1% Indica Dominant |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
THC Dominant |
THC content around 19-20% and CBD content ≤ 1% Indica Dominant |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
Balanced content of CBD – THC |
CBD content around 13-14% and THC content around 9-10% Indica / Sativa Hybrid Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
Balanced content of CBD – THC |
CBD content around 13-14% and THC content around 9-10% Indica / Sativa Hybrid Strain |
Helps with*: Chronic Pain, Spasticity, Nausea and Vomiting induced by chemotherapy, Appetite Stimulation |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
CBD Dominant |
CBD content around 18-19% and THC content ≤ 1% Indica Dominant |
Helps with*: Chronic Pain, Spasticity |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
Strain Profile |
CBD Dominant |
CBD content around 18-19% and THC content ≤ 1% Indica Dominant |
Helps with*: Chronic Pain, Spasticity |
Terpene Profile |
|
*The approved indications may vary on a country by country basis. |
The Tikun CBD food supplement range includes 5 products and targets everyday discomforts while also benefitting the whole body by providing holistic, natural balance.
Learn MoreLifelab CBD food supplement range includes 5 products and targets everyday discomforts while also benefitting the whole body by providing holistic, natural balance.
Learn More